SecSonar.com

STERIS plc (STE)

STERIS plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

STERIS plc (STE) is a Medical - Devices company based in IE with a market capitalization of $20.9B. Revenue grew 8.7% year-over-year and the company generated $972.4M in free cash flow. This page tracks STE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IE · 18K employees · IPO Jun 1, 1992

Valuation

Valuation & price

$212.11 · as of May 17, 2026 · -21.0% vs 52w high

26.7

P/E ratio

Latest-FY diluted EPS

2.90

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$269$234$199Jul 25Dec 25Jul 26Jul 7, 25$233.32Jul 9, 25$231.28Jul 11, 25$228.03Jul 15, 25$228.84Jul 17, 25$224.59Jul 21, 25$222.65Jul 23, 25$225.47Jul 25, 25$230.46Jul 29, 25$228.37Jul 31, 25$226.49Aug 4, 25$228.43Aug 6, 25$221.21Aug 11, 25$241.62Aug 13, 25$247.07Aug 15, 25$245.56Aug 19, 25$247.62Aug 21, 25$247.50Aug 25, 25$248.48Aug 27, 25$248.98Aug 29, 25$245.06Sep 3, 25$242.46Sep 5, 25$245.30Sep 9, 25$248.39Sep 11, 25$252.43Sep 16, 25$247.99Sep 18, 25$250.50Sep 22, 25$249.71Sep 24, 25$245.99Sep 26, 25$249.08Sep 30, 25$247.44Oct 2, 25$242.40Oct 6, 25$240.64Oct 8, 25$242.33Oct 10, 25$235.83Oct 14, 25$237.81Oct 16, 25$240.30Oct 21, 25$242.03Oct 23, 25$241.85Oct 27, 25$240.91Oct 29, 25$236.79Oct 31, 25$235.70Nov 4, 25$241.85Nov 6, 25$260.06Nov 10, 25$264.01Nov 12, 25$267.99Nov 14, 25$258.41Nov 18, 25$257.00Nov 20, 25$256.98Nov 25, 25$267.79Nov 28, 25$266.28Dec 2, 25$259.30Dec 4, 25$261.02Dec 8, 25$261.41Dec 10, 25$258.84Dec 12, 25$251.79Dec 16, 25$253.03Dec 18, 25$251.55Dec 22, 25$255.13Dec 24, 25$255.68Dec 29, 25$256.22Jan 2, 26$250.04Jan 6, 26$260.03Jan 8, 26$260.68Jan 12, 26$260.77Jan 14, 26$264.25Jan 16, 26$268.65Jan 21, 26$261.18Jan 23, 26$259.52Jan 27, 26$263.07Jan 29, 26$261.64Feb 2, 26$264.24Feb 4, 26$264.27Feb 9, 26$245.40Feb 11, 26$243.47Feb 13, 26$248.35Feb 18, 26$249.35Feb 20, 26$250.65Feb 24, 26$246.74Feb 26, 26$254.70Mar 2, 26$247.77Mar 4, 26$243.07Mar 6, 26$230.51Mar 10, 26$222.08Mar 12, 26$212.35Mar 17, 26$220.13Mar 19, 26$217.92Mar 23, 26$221.00Mar 25, 26$223.38Mar 27, 26$219.40Mar 31, 26$221.13Apr 2, 26$218.71Apr 7, 26$219.22Apr 9, 26$223.75Apr 13, 26$224.85Apr 15, 26$221.50Apr 17, 26$225.79Apr 22, 26$223.55Apr 24, 26$221.80Apr 28, 26$219.75Apr 30, 26$216.88May 4, 26$212.25May 6, 26$214.52May 8, 26$207.45May 12, 26$210.85May 14, 26$215.98May 18, 26$212.87May 20, 26$215.97May 22, 26$216.57May 28, 26$215.40Jun 1, 26$211.07Jun 3, 26$210.19Jun 5, 26$212.35Jun 9, 26$212.88Jun 11, 26$207.22Jun 15, 26$205.93Jun 17, 26$199.40Jun 22, 26$200.40Jun 24, 26$207.17Jun 26, 26$215.67Jul 2, 26$218.20
$199.4052-week range$268.65
Loading valuation history…

Fundamentals

Key fundamentals

$20.9B

Market cap

8.7%

Revenue growth (YoY)

44.3%

Gross margin

$972.4M

Free cash flow (USD)

$1.5B

Net debt

-0.4%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2026

FY 2017$2.6BFY 2018$2.6BFY 2019$2.8BFY 2020$3.0BFY 2021$3.1BFY 2022$4.2BFY 2023$4.5BFY 2024$5.1BFY 2025$5.5BFY 2026$5.9B
$2.6B$5.9B

Free cash flow by year

2017 → 2026

FY 2017$251.2MFY 2018$292.2MFY 2019$349.8MFY 2020$376.0MFY 2021$450.4MFY 2022$397.2MFY 2023$395.0MFY 2024$612.9MFY 2025$778.0MFY 2026$972.4M
$251.2M$972.4M

Gross margin by year

2022 → 2026

FY 202244.6%FY 202343.7%FY 202443.2%FY 202544.0%FY 202644.3%
44.6%44.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

3

Insider sells · 90 days

Earnings

Last report: 10-K filed May 29, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $297KZangerle John Adam · Sr. VP, Gen Counsel, and Sec. · $297KJun 16, 2026Filing
  • Insider sellInsider Sell $947KCarestio Daniel A · Director, President and CEO · $946.8KJun 8, 2026Filing
  • Insider sellInsider Sell $310KBreeden Richard C · Director · $310.3KJun 4, 2026Filing
  • Annual report10-K FiledMay 29, 2026Filing
  • 8-K eventEarnings ReleaseMay 11, 2026Filing
  • 8-K eventDirector Retirement and AppointmentMay 7, 2026Filing
  • 8-K eventCFO Transition Agreement AmendmentApr 6, 2026Filing

Questions

Frequently asked questions

What is STERIS plc's market cap?

STERIS plc (STE) has a market capitalization of $20.9B.

What is STE's P/E ratio?

STE trades at a price-to-earnings ratio of 26.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is STE's price-to-book (P/B) ratio?

STE trades at 2.90 times book value per share.

Are insiders buying STE stock?

SEC Form 4 filings show no open-market insider buys at STERIS plc in the last 90 days (3 sells).

Same arena

Related companies in Medical - Devices

PHG

Koninklijke Philips N.V.

$25.3B

ZBH

Zimmer Biomet Holdings, Inc.

$16B

RMD

ResMed Inc.

$28.3B

DXCM

DexCom, Inc.

$28.4B

SNN

Smith & Nephew plc

$12.7B

ALGN

Align Technology, Inc.

$12.6B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.